Natural Capsules Balance Sheet Annual

Trade

BSE: 524654 | NSE: - | ISIN: INE936B01015 | Sector: Biotechnology & Drugs

287.00 -10.50 (-3.53%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	11.09	6.55	3.48	2.09
Cash Equivalents	2.25	0.00	1.40	0.10
Cashand Short Term Investments	13.34	6.55	4.88	2.18
Accounts Receivable- Trade Net	54.47	52.13	26.30	26.70
Total Receivables Net	54.47	79.81	26.50	26.90
Total Inventory	19.04	13.75	4.58	6.61
Other Current Assets Total	36.92	1.29	39.62	6.25
Total Current Assets	123.77	101.51	75.58	41.94
Property/ Plant/ Equipment Total- Net	246.10	183.36	84.85	45.08
Intangibles Net	0.48	1.11	1.74	-
Long Term Investments	6.09	2.76	2.10	1.33
Other Long Term Assets Total	0.09	0.03	0.00	8.69
Total Assets	376.53	288.76	164.28	97.04
Accounts Payable	30.42	27.43	17.66	16.33
Current Portof LT Debt/ Capital Leases	41.06	4.10	1.75	-
Other Currentliabilities Total	4.99	13.37	10.78	7.91
Total Current Liabilities	76.47	66.94	46.45	33.87
Long Term Debt	67.93	70.39	32.57	-
Capital Lease Obligations	0.01	0.26	0.51	-
Total Long Term Debt	67.95	70.65	33.08	0.00
Total Debt	109.01	96.79	51.10	9.63
Deferred Income Tax	3.30	2.77	1.68	0.96
Minority Interest	25.00	25.02	0.00	0.00
Other Liabilities Total	0.00	0.15	0.08	0.12
Total Liabilities	172.73	165.54	81.30	34.95
Common Stock Total	9.33	9.28	7.01	6.23
Retained Earnings( Accumulated Deficit)	194.47	76.70	75.97	55.86
Total Equity	203.80	123.23	82.98	62.10
Total Liabilities Shareholders' Equity	376.53	288.76	164.28	97.04
Total Common Shares Outstanding	0.93	0.92	0.62	0.76
Tangible Book Valueper Share Common Eq	217.48	132.27	130.34	81.69
Prepaid Expenses	-	0.10	-	-
Property/ Plant/ Equipment Total- Gross	-	235.13	20.11	6.98
Accumulated Depreciation Total	-	-51.77	-	-
Notes Payable/ Short Term Debt	-	22.05	16.27	9.63
Additional Paid- In Capital	-	37.25	-	-
Other Equity Total	-	0.00	-	-